Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody

Completed

Conditions studied: Clostridium Enterocolitis, Pseudomembranous Colitis, Antibiotic-Associated Colitis

In brief

The purpose of this study is three fold: 1)To collect serum from patients with documented Clostridium difficile infection and test for the presence of antibody to C. difficile toxin at the start and at the end of therapy, and again if a relapse or recurrence occurs. 2)To collect stool samples for test of C. difficile toxin at similar time intervals. 3)To assay random serum samples from the VA lab in order to determine the rate of antibody to C. difficile toxin in our patient population.

Key facts

Study ID

NCT00304408

Run by

Michael E. DeBakey VA Medical Center

People needed

10

Starts

2005-01-01

Expected to finish

2008-01-01

Last updated by the study team

2010-09-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients at the Houston VA with documented C. difficile infection

You may not qualify if…

• None

Where it is running

• Michael E. Debakey VA Medical Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.